Intercalative binding to DNA of antitumour drugs derived from 3-nitro-1,8-naphthalic acid
- PMID: 573892
- PMCID: PMC328007
- DOI: 10.1093/nar/7.1.217
Intercalative binding to DNA of antitumour drugs derived from 3-nitro-1,8-naphthalic acid
Abstract
Two new antitumour drugs, imide derivatives of 3-nitro-1,8-naphthalic acid having different basic side chains linked to the imide nitrogen, have been shown to bind to double-helical DNA by intercalation. At ionic strength 0.01 mol/litre, pH 7, their intrinsic association constants are about 1.45 x 10(5) M-1 and each bound ligand molecule occludes about 3.4 nucleotides of the DNA lattice. They remove and reverse the supercoiling of closed circular duplex PM2 DNA with apparent unwinding angles of 11-12 degrees per bound drug molecule, referred to an assumed unwinding angle of 26 degrees for ethidium. They increase the viscosity of sonicated rod-like DNA fragments, each bound drug molecule producing a calculated increment in length of 2.2 - 2.5 A. No important differences between the DNA-binding characteristics of the two drugs were detected, though one appears marginally more active than the other in certain biological tests.
Similar articles
-
Effects of ring substituents and linker chains on the bifunctional intercalation of diacridines into deoxyribonucleic acid.Biochemistry. 1980 Dec 9;19(25):5825-36. doi: 10.1021/bi00566a026. Biochemistry. 1980. PMID: 7193050
-
The binding of echinomycin to deoxyribonucleic acid.Biochem J. 1976 Sep 1;157(3):721-40. doi: 10.1042/bj1570721. Biochem J. 1976. PMID: 985413 Free PMC article.
-
The effect of ionic strength on DNA-ligand unwinding angles for acridine and quinoline derivatives.Nucleic Acids Res. 1980 Apr 11;8(7):1613-24. doi: 10.1093/nar/8.7.1613. Nucleic Acids Res. 1980. PMID: 7191995 Free PMC article.
-
[DNA intercalators: their interaction with DNA and other cell components and their use in biological research].Tsitologiia. 1991;33(10):3-31. Tsitologiia. 1991. PMID: 1814033 Review. Russian.
-
Review: ethidium fluorescence assays. Part 1. Physicochemical studies.Nucleic Acids Res. 1979 Oct 10;7(3):547-69. doi: 10.1093/nar/7.3.547. Nucleic Acids Res. 1979. PMID: 41222 Free PMC article. Review.
Cited by
-
Phase II study of amonafide in advanced pancreatic adenocarcinoma.Invest New Drugs. 1991 Nov;9(4):353-6. doi: 10.1007/BF00183580. Invest New Drugs. 1991. PMID: 1804812 Clinical Trial.
-
Imide derivatives of 3-nitro-1.8-naphthalic acid: their inhibitory activity against DNA viruses.Arch Virol. 1982;74(2-3):157-65. doi: 10.1007/BF01314709. Arch Virol. 1982. PMID: 6299235
-
Phase I study of mitonafide with a 3-day administration schedule: early interruption due to severe central nervous system toxicity.Invest New Drugs. 1994;12(4):277-81. doi: 10.1007/BF00873041. Invest New Drugs. 1994. PMID: 7775127 Clinical Trial.
-
Phase II trial of amonafide in advanced pancreas cancer. A Southwest Oncology Group study.Invest New Drugs. 1993 May-Aug;11(2-3):219-21. doi: 10.1007/BF00874159. Invest New Drugs. 1993. PMID: 8262735 Clinical Trial.
-
UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis.Onco Targets Ther. 2017 Nov 6;10:5303-5309. doi: 10.2147/OTT.S145518. eCollection 2017. Onco Targets Ther. 2017. PMID: 29158682 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources